Israel’s Nevia Bio (previously Gina Life) specializes in women’s health, using its innovative machine-learning platform to detect diseases while they are still curable. Nevia is initially targeting ovarian cancer, which has a less than 20% survival rate at stage 3 and currently has no early detection.

https://www.calcalistech.com/ctechnews/article/sykpcf119n

https://www.nevia.bio/